Molecular imaging using Ga-68-HER2 PET/CT provides a whole-body visualization of receptor expression that traditional anatomical scans simply cannot match. This breakthrough addresses a significant clinical hurdle in managing HER2-positive breast cancer, which represents nearly a quarter of all
Total-body PET/CT represents a fundamental shift in medical physics, moving the industry away from the rigid trade-offs between image quality and scanning speed. For decades, the nuclear medicine community has been constrained by the physical limitations of short-axial field-of-view (SA-FOV)
Advanced machine learning models are now capable of interpreting preoperative MRI scans to identify highly aggressive liver tumors before a surgical incision is ever made. This breakthrough, originating from a significant multicenter research initiative in China, represents a pivotal shift in how
Economic barriers to advanced diagnostics are falling as the cost of DNA quantification in major Chinese medical centers is now comparable to standard RNA viral load testing. This shift is critical as the global effort to eradicate HIV/AIDS continues to be anchored in the ambitious 95-95-95 targets
Effective breast cancer management now relies on imaging to track the patient's response to therapy and adjust treatment plans in real time. This dynamic approach marks a significant departure from the static, population-based screening models that dominated the medical landscape for decades. As
The ability to monitor the wash-in and wash-out phases of a contrast agent in real time is essential for navigating the complicated diagnostic landscape of liver disease. This environment is frequently clouded by the presence of "imposter" lesions—masses that mimic the appearance of malignancy on
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65
